Nelarabine 70710-1726-01
- Manufacturer
- Zydus Pharmaceuticals Usa Inc.
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 17, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA215037
Need to source Nelarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nelarabine | 5 mg/mL |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Selected Package
70710-1726-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1726-1) / 50 mL in 1 VIAL, SINGLE-DOSE
Other packages for this product(1)
6 VIAL, SINGLE-DOSE in 1 CARTON (70710-1726-8) / 50 mL in 1 VIAL, SINGLE-DOSE